Vanguard Group Inc Evolus, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Evolus, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,318,250 shares of EOLS stock, worth $21.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,318,250

Previous 3,234,068 2.6%

Holding current value

$21.2 Million

Previous $38.9 Million 21.45%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$9.1 - $12.22 $766,056 - $1.03 Million	84,182 Added 2.6%	3,318,250 $30.6 Million
Q1 2025 May 09, 2025	BUY	$9.47 - $15.04 $593,428 - $942,466	62,664 Added 1.98%	3,234,068 $38.9 Million
Q4 2024 Feb 11, 2025	SELL	$10.84 - $17.45 $259,368 - $417,526	-23,927 Reduced 0.75%	3,171,404 $35 Million
Q3 2024 Nov 13, 2024	BUY	$10.66 - $17.48 $2.24 Million - $3.67 Million	210,116 Added 7.04%	3,195,331 $51.8 Million
Q2 2024 Aug 13, 2024	BUY	$10.45 - $13.76 $832,917 - $1.1 Million	79,705 Added 2.74%	2,985,215 $32.4 Million
Q1 2024 May 10, 2024	SELL	$9.99 - $14.91 $379,639 - $566,609	-38,002 Reduced 1.29%	2,905,510 $40.7 Million
Q4 2023 Feb 14, 2024	BUY	$7.6 - $10.53 $1.86 Million - $2.58 Million	244,865 Added 9.07%	2,943,512 $31 Million
Q3 2023 Nov 14, 2023	BUY	$7.15 - $10.2 $5.3 Million - $7.56 Million	741,451 Added 37.88%	2,698,647 $24.7 Million
Q2 2023 Aug 14, 2023	BUY	$7.23 - $10.52 $386,544 - $562,441	53,464 Added 2.81%	1,957,196 $14.2 Million
Q1 2023 May 15, 2023	BUY	$7.81 - $11.05 $152,537 - $215,817	19,531 Added 1.04%	1,903,732 $16.1 Million
Q4 2022 Feb 10, 2023	BUY	$6.52 - $8.95 $50,940 - $69,926	7,813 Added 0.42%	1,884,201 $14.2 Million
Q3 2022 Nov 14, 2022	BUY	$7.76 - $13.72 $216,084 - $382,047	27,846 Added 1.51%	1,876,388 $15.1 Million
Q2 2022 Aug 12, 2022	BUY	$10.22 - $13.94 $422,331 - $576,056	41,324 Added 2.29%	1,848,542 $21.4 Million
Q1 2022 May 13, 2022	BUY	$5.22 - $11.78 $364,376 - $822,291	69,804 Added 4.02%	1,807,218 $20.3 Million
Q4 2021 Feb 14, 2022	BUY	$5.37 - $8.38 $236,967 - $369,792	44,128 Added 2.61%	1,737,414 $11.3 Million
Q3 2021 Nov 12, 2021	BUY	$7.36 - $13.67 $119,254 - $221,495	16,203 Added 0.97%	1,693,286 $12.9 Million
Q2 2021 Aug 13, 2021	BUY	$8.42 - $13.96 $14.1 Million - $23.4 Million	1,677,083 New	1,677,083 $21.2 Million

Others Institutions Holding EOLS

# of Institutions

186

Shares Held

55.6M

Call Options Held

1.21M

Put Options Held

48.5K

View Full List

About Evolus, Inc.

Ticker EOLS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 56,094,800
Market Cap $359M
Description
Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...

More about EOLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Evolus, Inc. Transaction History